Viral infections affecting the liver have had an important impact on humanity, as they have
led to significant morbidity and mortality in patients with acute and chronic infections. Once …

Hepatitis D is caused by the hepatitis D virus (HDV), a unique RNA pathogen that requires
the hepatitis B surface antigen (HBsAg) to infect. Hepatitis D is transmitted by the parenteral …

Among adults in the 2011-2016 National Health and Nutrition Examination Survey
(NHANES), the estimated prevalence of hepatitis B surface antigen (HBsAg) was 0.36 …

In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …

Chronic hepatitis D is the most severe form of viral hepatitis, affecting∼ 20 million HBV-
infected people worldwide. The causative agent, hepatitis delta virus (HDV), is a unique …

Background & Aims Hepatitis delta virus (HDV) infection accelerates the progression of
hepatitis B virus (HBV)-related liver disease. We assessed the epidemiological …

Hepatitis delta virus (HDV) infection of humans was first reported in 1977, and now it is now
estimated that 15–20 million people are infected worldwide. Infection with HDV can be an …

Background & Aims Low hepatitis delta prevalence estimates in the United States are likely
biased due to low testing rates. The objectives of this study were to quantify the prevalence …

This review aims to summarize the current evidence on the treatment of viral hepatitis,
focusing on its clinical management. Also, future treatment options and areas of potential …

With recent studies showing increased prevalence of hepatitis delta (HDV) even in the US,
Australia, and some countries in Europe, and very high prevalence in endemic regions, HDV …